Skip to content
Back to Guavy Wire
Stocks

Boeing Shares Soar on Rare Double Upgrade and FAA 737 MAX Certification

Instruments
BA
Share

Boeing's stock surged nearly 7% on Monday after two major developments boosted its turnaround narrative. BNP Paribas upgraded Boeing to 'Outperform' from 'Underperform', marking a rare double upgrade, and raised its price target to $300, implying an upside of nearly 39%. The firm said the 'post-COVID era of uncertainty' for Boeing is over, with certifications expected to drive inventory liquidation and improve operational stability. BNP Paribas also sees a multi-billion-dollar tailwind from higher 737 MAX production as aircraft output ramps up.

The Federal Aviation Administration (FAA) certified the long-delayed 737 MAX 7 after nearly a decade of delays, removing a key regulatory hurdle for the aircraft. The agency required key improvements, including updates to the flight-control software and engine anti-ice system. Boeing is also awaiting FAA certification for the larger 737 MAX 10 and the 777X.

Stocktwits traders said the analyst upgrade and MAX 7 approval strengthen Boeing's recovery story, with one trader calling it 'an important upgrade' and another saying it removes another hurdle for the company's turnaround. BA shares have gained around 6% year to date.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc